Status:
COMPLETED
Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy
Lead Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Conditions:
Breast Cancer
Breast-conserving Surgery
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
Aspirative drainage continues to be the "gold standard" for the management of this post-surgical complication, even though it can lead to complications such as obstruction of the drainage, peritubal l...
Detailed Description
1. Introduction: In the surgical management of breast cancer, a conservative approach is the "gold standard" for the mammary region. For the axillary region, however, this depends on the results o...
Eligibility Criteria
Inclusion
- Diagnosis of breast cancer,
- scheduled for surgical treatment including conservative surgery and ALND.
- Signed informed consent for ALND.
Exclusion
- Selective sentinel node biopsy negative.
- Subsidiary mastectomy patients.
- Denial of informed consent for axillary lymphadenectomy.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2023
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT04487561
Start Date
March 1 2020
End Date
February 14 2023
Last Update
February 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico Universitario de Valencia
Valencia, Spain, 46010